| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
264,900,000 |
| Market
Cap: |
8.27(B) |
| Last
Volume: |
49,305,461 |
Avg
Vol: |
7,165,494 |
| 52
Week Range: |
$12.46 - $31.23 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 606 |
| Guru Rank Value : 3 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile ImmunoGen is a clinical-stage biotechnology company focused on developing the antibody-drug conjugates (ADCs). Co.'s main program is mirvetuximab, an ADC targeting folate receptor alpha, a cell-surface protein overexpressed in a number of epithelial tumors, including ovarian, endometrial, and non-small-cell lung cancers. Pivekimab sunirine is an ADC comprised of an antibody designed to target CD123 with site-specific conjugation to a DNA-alkylating payload of the IGN (indolinobenzodiazepine pseudodimer) class. Co.'s pipeline program, IMGC936, is an ADC that is designed to target ADAM9, an enzyme overexpressed in a range of solid tumors and implicated in tumor progression and metastasis.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
233,563 |
4,785,085 |
4,785,085 |
| Total Sell Value |
$0 |
$6,909,682 |
$86,338,289 |
$86,338,289 |
| Total People Sold |
0 |
4 |
5 |
5 |
| Total Sell Transactions |
0 |
6 |
26 |
26 |
| End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Carter David Warren |
Director |
– • – |
2010-11-01 |
4 |
S |
$7.99 |
$359,564 |
D/D |
(45,000) |
0 |
|
- |
|
| Pien Howard H |
Director |
– • – |
2009-12-28 |
5 |
S |
$8.05 |
$17,452 |
D/D |
(2,168) |
0 |
|
- |
|
| Lambert John |
Executive Vice President |
• – – |
2009-11-24 |
4 |
S |
$8.45 |
$228,442 |
D/D |
(27,025) |
65,586 |
|
- |
|
| Lambert John |
Executive Vice President |
• – – |
2009-11-24 |
4 |
OE |
$6.78 |
$232,724 |
D/D |
34,320 |
92,611 |
|
- |
|
| Sayare Mitchel |
Director |
– • – |
2009-11-20 |
4 |
S |
$8.02 |
$26,169 |
D/D |
(3,263) |
533,136 |
|
- |
|
| Sayare Mitchel |
Director |
– • – |
2009-11-20 |
4 |
OE |
$6.78 |
$24,690 |
D/D |
3,641 |
536,399 |
|
- |
|
| Lambert John |
Executive Vice President |
• – – |
2009-11-20 |
4 |
S |
$8.41 |
$177,605 |
D/D |
(21,117) |
58,291 |
|
- |
|
| Lambert John |
Executive Vice President |
• – – |
2009-11-20 |
4 |
OE |
$6.78 |
$143,194 |
D/D |
21,117 |
79,408 |
|
- |
|
| Sayare Mitchel |
Director |
– • – |
2009-11-19 |
4 |
S |
$8.05 |
$587,431 |
D/D |
(73,000) |
532,758 |
|
- |
|
| Sayare Mitchel |
Director |
– • – |
2009-11-19 |
4 |
OE |
$6.78 |
$551,695 |
D/D |
81,359 |
605,758 |
|
- |
|
| Lambert John |
Executive Vice President |
• – – |
2009-11-18 |
4 |
S |
$8.41 |
$122,446 |
D/D |
(14,563) |
58,291 |
|
- |
|
| Lambert John |
Executive Vice President |
• – – |
2009-11-18 |
4 |
OE |
$6.78 |
$98,752 |
D/D |
14,563 |
72,854 |
|
- |
|
| Pien Howard H |
Director |
– • – |
2009-11-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,168 |
|
- |
|
| Sayare Mitchel |
Director |
– • – |
2009-11-06 |
4 |
S |
$7.87 |
$393,500 |
D/D |
(50,000) |
524,399 |
|
- |
|
| Sayare Mitchel |
Director |
– • – |
2009-11-05 |
4 |
S |
$7.38 |
$1,107,000 |
D/D |
(150,000) |
574,399 |
|
- |
|
| Carter David Warren |
Director |
– • – |
2009-11-03 |
4 |
S |
$6.78 |
$135,520 |
D/D |
(20,000) |
45,000 |
|
- |
|
| Carter David Warren |
Director |
– • – |
2009-11-02 |
4 |
S |
$6.75 |
$135,040 |
D/D |
(20,000) |
65,000 |
|
- |
|
| Korsant Philip B |
10% Owner |
– – • |
2009-07-31 |
4 |
S |
$8.64 |
$30,240,000 |
D/D |
(3,500,000) |
5,525,200 |
|
- |
|
| Sayare Mitchel |
Chairman of the Board |
• • – |
2009-01-05 |
4 |
OE |
$2.25 |
$180,000 |
D/D |
80,000 |
733,288 |
|
- |
|
| Lambert John |
Executive Vice President |
• – – |
2008-12-08 |
4 |
OE |
$2.25 |
$60,750 |
D/D |
27,000 |
58,291 |
|
- |
|
| Lambert John |
Executive Vice President |
• – – |
2008-12-03 |
4 |
S |
$3.59 |
$41,668 |
D/D |
(11,600) |
31,291 |
|
- |
|
| Lambert John |
Executive Vice President |
• – – |
2008-12-03 |
4 |
OE |
$2.25 |
$26,100 |
D/D |
11,600 |
43,891 |
|
- |
|
| Lambert John |
Executive Vice President |
• – – |
2008-11-28 |
4 |
S |
$3.75 |
$58,121 |
D/D |
(15,400) |
31,291 |
|
- |
|
| Lambert John |
Executive Vice President |
• – – |
2008-11-28 |
4 |
OE |
$2.25 |
$34,650 |
D/D |
15,400 |
46,691 |
|
- |
|
| Zbi Equities, L.l.c. |
10% Owner |
– – • |
2008-06-20 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
9,046,200 |
|
- |
|
453 Records found
|
|
Page 15 of 19 |
|
|
